Habitat Radiomics Based on Diffusion-weighted MRI for Predicting PARP Inhibitor Resistance in Advanced High-grade Serous Ovarian Cancer

This publication has 36 references indexed in Scilit:

• MRI-based habitat analysis for pathologic response prediction after neoadjuvant chemoradiotherapy in rectal cancer: a multicenter study
  European Radiology, 2025
• Can we cut the contrast? DWI shows similar value to standard MRI for assessing treatment response in breast cancer
  European Radiology, 2025
• Habitat Radiomics and Deep Learning Features Based on CT for Predicting Lymphovascular Invasion in T1-stage Lung Adenocarcinoma: A Multicenter Study
  Academic Radiology, 2025
• Methodological issues in radiomics: impact on accuracy of MRI for predicting response to neoadjuvant chemotherapy in breast cancer
  European Radiology, 2024
• Dissecting the Distinct Tumor Microenvironments of HRD and HRP Ovarian Cancer: Implications for Targeted Therapies to Overcome PARPi Resistance in HRD Tumors and Refractoriness in HRP Tumors
  Advanced Science, 2024
• Habitat Radiomics Based on MRI for Predicting Platinum Resistance in Patients with High-Grade Serous Ovarian Carcinoma: A Multicenter Study
  Academic Radiology, 2023
• Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer
  Drug Resistance Updates, 2021
• Prediction of Platinum-based Chemotherapy Response in Advanced High-grade Serous Ovarian Cancer: ADC Histogram Analysis of Primary Tumors
  Academic Radiology, 2021
• The forefront of ovarian cancer therapy: update on PARP inhibitors
  Annals of Oncology, 2020
• MR image-based radiomics to differentiate type Ι and type ΙΙ epithelial ovarian cancers
  European Radiology, 2020